Logo image of EVH

EVOLENT HEALTH INC - A (EVH) Stock Price, Quote, News and Overview

NYSE:EVH - New York Stock Exchange, Inc. - US30050B1017 - Common Stock - Currency: USD

10.41  -0.01 (-0.1%)

EVH Quote, Performance and Key Statistics

EVOLENT HEALTH INC - A

NYSE:EVH (1/29/2025, 2:33:39 PM)

10.41

-0.01 (-0.1%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High35
52 Week Low9.74
Market Cap1.21B
Shares116.56M
Float112.49M
Yearly DividendN/A
Dividend YieldN/A
PE11.44
Fwd PE10.35
Earnings (Next)02-19 2025-02-19/amc
IPO06-05 2015-06-05


EVH short term performance overview.The bars show the price performance of EVH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40 -50

EVH long term performance overview.The bars show the price performance of EVH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of EVH is 10.41 USD. In the past month the price decreased by -8.11%. In the past year, price decreased by -65%.

EVOLENT HEALTH INC - A / EVH Daily stock chart

EVH Latest News, Press Releases and Analysis

News Image
2 days ago - Evolent Health, Inc.

Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it...

News Image
a month ago - Evolent Health, Inc.

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1

/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the...

News Image
2 months ago - Benzinga

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining

Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.

News Image
3 months ago - The Motley Fool

Evolent Health (EVH) Q3 2024 Earnings Call Transcript

EVH earnings call for the period ending September 30, 2024.

EVH Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 36.86 37.40B
DOCS DOXIMITY INC-CLASS A 51.66 10.80B
WAY WAYSTAR HOLDING CORP N/A 6.98B
CERT CERTARA INC 35.33 2.22B
SDGR SCHRODINGER INC N/A 1.85B
GDRX GOODRX HOLDINGS INC-CLASS A 14.83 1.81B
TDOC TELADOC HEALTH INC N/A 1.79B
PHR PHREESIA INC N/A 1.68B
HSTM HEALTHSTREAM INC 49.91 986.45M
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 936.77M
DH DEFINITIVE HEALTHCARE CORP 14.4 758.63M
SLP SIMULATIONS PLUS INC 60.2 677.23M

About EVH

Company Profile

EVH logo image Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 4,700 full-time employees. The company went IPO on 2015-06-05. The firm offers three primary solutions: specialty care management services, total cost of care management and administrative services. The company provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Company Info

EVOLENT HEALTH INC - A

800 N Glebe Rd Ste 500

Arlington VIRGINIA 22203 US

CEO: Seth Blackley

Employees: 4700

Company Website: https://www.evolenthealth.com/

Investor Relations: https://ir.evolenthealth.com/

Phone: 15713896000

EVH FAQ

What is the stock price of EVH?

The current stock price of EVH is 10.41 USD.


What is the symbol for EVOLENT HEALTH INC - A stock?

The exchange symbol of EVOLENT HEALTH INC - A is EVH and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is EVH stock listed?

EVH stock is listed on the New York Stock Exchange, Inc. exchange.


Is EVH a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for EVH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of EVH.


Does EVH stock pay dividends?

EVH does not pay a dividend.


When does EVH stock report earnings?

EVH will report earnings on 2025-02-19, after the market close.


What is the Price/Earnings (PE) ratio of EVH?

The PE ratio for EVH is 11.44. This is based on the reported non-GAAP earnings per share of 0.91 and the current share price of 10.41 USD.


What is the Short Interest ratio of EVH stock?

The outstanding short interest for EVH is 9.06% of its float.


EVH Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EVH Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to EVH. Both the profitability and financial health of EVH have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EVH Financial Highlights

Over the last trailing twelve months EVH reported a non-GAAP Earnings per Share(EPS) of 0.91. The EPS decreased by 21.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.17%
ROE -8.5%
Debt/Equity 0.49
Chartmill High Growth Momentum
EPS Q2Q%-86.67%
Sales Q2Q%21.6%
EPS 1Y (TTM)21.33%
Revenue 1Y (TTM)37.65%

EVH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to EVH. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of -15.27% and a revenue growth 31.22% for EVH


Ownership
Inst Owners114.02%
Ins Owners1.26%
Short Float %9.06%
Short Ratio3.68
Analysts
Analysts84.21
Price Target25.59 (145.82%)
EPS Next Y-15.27%
Revenue Next Year31.22%